Synthetic Biology Market Size, Demand & Growth Report 2032
Global Synthetic Biology Market Size, Share Analysis Report, 2024-2032

Synthetic Biology Market Size, Share & Trends Analysis Report By Product (Enzymes, Cloning Technologies Kits), By Technology (PCR, NGS), By Application (Non-healthcare, Healthcare), And Segment Forecasts, 2023 - 2032

  • Published Date:Jan-2024
  • Pages: 118
  • Format: PDF
  • Report ID: PM3239
  • Base Year: 2023
  • Historical Data: 2019-2022

Report Outlook

The global synthetic biology market size and share was valued at USD 15.47 billion in 2023 and is expected to grow at a CAGR of 18.6% during the forecast period. The demand for synthetic biology will increase due to the expanding range of uses for multiplexed diagnostics & cellular recording, as well as therapeutic genome editing. The application of organisms and goods created through synthetic biology techniques in other industries, such as energy and chemicals, is also likely to have an effect on the market's overall growth.

Synthetic biology is a field of science that focuses on the application of engineering principles to biology. It’s an interdisciplinary area that includes a variety of methodologies from several disciplines, including biomaterials, biotechnology, systems biology, chemical and biological engineering, electrical and computer engineering, and evolutionary biology. Synthetic biology involves redesigning microorganisms for useful purposes. Some of the primary goals of synthetic biology are identifying and cataloging standardized genomic parts to build novel biological systems and expanding the set of natural proteins for new processes.

Synthetic biology also aims at designing and constructing simple genomes for natural bacteria. There is a wide range of synthetic biology applications. It’s used in antibody discovery & NGS to create new diagnostics and therapeutics. Also, it’s utilized in microbial engineering for enhancing crop yields, soil remediation, and wastewater decontamination. Furthermore, synthetic biology is making significant strides in choosing wheat phenotypes that enhance yield and tolerance to environmental stresses. The rising need for renewable energy sources is one of the primary factors driving the synthetic biology market sales.

The market research report offers an in-depth analysis of the industry to support informed decision-making. It offers a meticulous breakdown of various market niches and keeps readers updated on the latest industry developments. Along with tracking the synthetic biology market on the basis of SWOT and Porter’s Five Forces models, the research report includes graphs, tables, charts, and other pictorial representations to help readers understand the key insights and important data easily. 

Synthetic Biology Market Size

Know more about this report: Request for sample pages

The use of synthetic biology products has grown over the last two years as a result of the COVID-19 outbreak. By implementing new methods for creating test kits, treatments, and vaccines for COVID-19, many major pharmaceutical and biotechnology companies as well as synthetic biology industry players have increased their research efforts worldwide. Synthetic biology is one of the emerging technologies, according to a report from the European Parliament. It can be applied to the fight against COVID-19 infection. The National Institute of Health in the United States has also highlighted the use of synthetic biology as a way to hasten the creation of vaccines.

The expansion of research and development efforts across numerous fields is anticipated to lead to an increase in the global market. Players are applying synthetic biology techniques to improve performance and increase the utilization of inexpensive inputs like waste in order to improve conventional biofuel production. For instance, biotechnology is being used by fashion businesses like Modern Meadow, Bolt Threads, and Vitro Labs to create sustainable materials.

Strong investments from corporate and public partnerships were seen in the industry. The startups in the synthetic biology sector raised 7.8 billion in investment in 2020 and 18.0 billion in 2021, according to data released by SynBioBeta. Companies like DNA Script and Arbor Biotechnologies raised about 215 million and 167.2 million dollars, respectively. The significant expenditure promotes the flow of money through the market and aids in the expansion of businesses along the supply chain.

The development of biofoundries, advancements in genome editing, the availability of natural materials, and sizable markets are also emphasized as worldwide strengths in synthetic biology for the creation of a biobased economy. Discussions of potential obstacles to the field's long-term growth, such as inadequate policies and infrastructure, are presented along with suggestions for solutions that include public-private partnerships, improved multilateral cooperation, and a strong governance framework.

The newest technologies are also being introduced by market participants to meet the rising demand and seize unexplored market opportunities. For instance, Creative Biogene launched its broad shRNA products in November 2021 to advance RNAi research. The business possesses a wide range of knowledge and experience to provide premium RNAi products, such as shRNA clones and siRNA libraries, with the goal of delivering efficient, practical, and dependable instruments to advance RNAi research.

For the clarification of biological phenomena and the accomplishment of specific design goals in synthetic biology, artificial intelligence (AI)/machine learning has recently surfaced as a viable alternative to systems biology. The current advancement of machine learning (ML) and artificial intelligence (AI) tools and techniques in the biological and biotechnological realms can be seen as a similar effort to improve and automate analysis and decision-making in these fields. For examining system behaviors and enhancing the output of interest in synthetic biology applications, AI/ML continues to be a viable option.

Industry Dynamics

Growth Drivers
Synthetic biology is a rapidly growing field combining engineering, biology, and computer science principles to create new biological systems and modify existing ones. Several key factors, including the increasing demand for renewable energy sources, the development of gene editing technologies, and the growing focus on precision medicine, drive the market for synthetic biology.

One of the major driving factors for the synthetic biology market is the need for renewable energy sources. With concerns over climate change and the depletion of traditional energy sources, there is a growing demand for alternative energy sources such as biofuels. Synthetic biology offers a way to engineer microorganisms to produce biofuels more efficiently and sustainably, leading to increased investment and research in the field.

Another driving factor for the synthetic biology market is the development of gene editing technologies such as CRISPR/Cas9. These technologies allow for precise modifications to be made to an organism's genome, which can be used to create new functions or traits. It led to increased interest in gene therapy and genetic engineering, with the potential for synthetic biology to revolutionize medicine and biotechnology.

Precision medicine is also a driving factor for the synthetic biology market, as the field offers the potential to develop personalized disease treatments. By engineering biological systems to target specific cells or tissues, synthetic biology can help create more effective and targeted therapies with fewer side effects.

Synthetic Biology Market Share

Report Segmentation

The market is primarily segmented based on Technology, Product, Application, and region.

By Product

By Technology

By Application

By Region

  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-Nucleic Acids
  • Chassis Organism


  • NGS Technology
  • PCR Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Other Technologies


  • Healthcare
  • Non-Healthcare
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report: Request for sample pages

In 2022, the oligonucleotide/oligo segment dominated the market

The main component in many molecular and synthetic biology uses is oligonucleotides. The main market movers for the same are the expanding use of targeted NGS, mutagenesis studies, DNA computing, and CRISPR gene editing. For instance, OligoMix is a cutting-edge and custom tool for genomic research. It produces a huge number of oligonucleotide sequences in simultaneously. The price is less than 0.8 cents per base for the same.

The PCR segment accounted for the highest market share of the market in 2022

In 2022, the PCR market segment accounted for the highest market share. PCR is an important tool for the identification and analysis of particular gene sequences is the Polymerase Chain Reaction (PCR). Since real-time PCR assays have great sensitivity and specificity, they are frequently used in PCR-based genomic studies. In many fields, including forensic science, DNA cloning, molecular diagnostics, and genomics, this method is widely used.

Healthcare is expected to hold a significant revenue share during forecast period

Synthetic biology-based diagnostics offer a highly accurate, quick, non-invasive, and real-time method for identifying pathogens, cancer cells, and medicines. Researchers use rational engineering methods to create novel, dynamic biosensing devices made up of a processor, sensor, and reporter. A rise in neurological diseases like multiple sclerosis is also fueling this market.

The synthetic biology market also benefits from advancements in computer science and artificial intelligence. These technologies allow for the design and simulation of biological systems, accelerating the development and testing of new products and solutions.

Furthermore, the rise of synthetic biology has also created opportunities for new businesses and startups to enter the market. With the increasing availability of resources and tools, more entrepreneurs can enter the field and bring their innovative ideas to market.

Synthetic Biology Market Size

North America dominated the synthetic biology market in 2022

In 2022, North America dominated the synthetic biology market due to rising private company investment, advantageous laws, and government support. In order to fuel the development of the synthetic biology market, the U.S. primarily focuses on research in the fields of proteomics, drug screening and discovery, and genomic structure prediction. The synthetic biology market is expected to grow at the fastest rate in the Asia Pacific region, which is expected to be fueled by factors such as rising investments in Asia Pacific nations, expanding partnerships & funding in the Chinese market, and expanding collaborations in the field of synthetic biology.

Synthetic Biology Market Size

Competitive Insight

Some of the major players operating in the global market include Biosciences Inc.; Codexis, Inc.; Creative Biogene; CREATIVE ENZYMES; Enbiotix, Inc.; Illumina, Inc.; Merck Kgaa (Sigma-Aldrich Co. LLC); New England Biolabs; Euro fins Scientific; Novozymes; Pareto Bio, Inc.

Recent Developments

  • Novozymes released Frontia GlutenEx in January 2021 aimed at wheat manufacturers to improve the recovery of the gluten protein while reducing the amount of energy used.
  • Merck and BioNTech (Germany) joined forces in February 2021 to furnish lipids for the creation of the Pfizer-BioNTech COVID-19 Vaccine. (BNT162b2).

Synthetic Biology Market Report Scope

Report Attributes


Market size value in 2024

USD 18.32 billion

Revenue Forecast in 2032

USD 71.51 billion


18.6% from 2024 - 2032

Base year


Historical data

2019 - 2022

Forecast period

2024 - 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2032

Segments Covered

By Product, By Technology, By Application, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Key Companies

Biosciences Inc.; Codexis, Inc.; Creative Biogene; CREATIVE ENZYMES; Enbiotix, Inc.; Illumina, Inc.; Merck Kgaa (Sigma-Aldrich Co. LLC); New England Biolabs; Euro fins Scientific; Novozymes; Pareto Bio, Inc.

Want to check out the synthetic biology market report before buying it? Then, our sample report has got you covered. It includes key market data points, ranging from trend analyses to industry estimates and forecasts. See for yourself by downloading the sample report. Download Sample Report Here


key companies in synthetic biology market are Biosciences Inc.; Codexis, Inc.; Creative Biogene; CREATIVE ENZYMES; Enbiotix, Inc.; Illumina, Inc.; Merck Kgaa (Sigma-Aldrich Co. LLC); New England Biolabs.

The global synthetic biology market expected to grow at a CAGR of 18.5% during the forecast period.

The synthetic biology market report covering key segments are technology, product, application and region.

key driving factors in synthetic biology market are Growing Research And Development Activities In Synthetic Biology.

The global synthetic biology market size is expected to reach USD 71.51 billion by 2032.